Drug repositioning: Progress and challenges in drug discovery for various diseases

Y Hua, X Dai, Y Xu, G Xing, H Liu, T Lu, Y Chen… - European Journal of …, 2022 - Elsevier
Compared with traditional de novo drug discovery, drug repurposing has become an
attractive drug discovery strategy due to its low-cost and high efficiency. Through a …

Fat and beyond: the diverse biology of PPARγ

P Tontonoz, BM Spiegelman - Annu. Rev. Biochem., 2008 - annualreviews.org
The nuclear receptor PPARγ is a ligand-activated transcription factor that plays an important
role in the control of gene expression linked to a variety of physiological processes. PPARγ …

Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARγ

F Wang, SE Mullican, JR DiSpirito… - Proceedings of the …, 2013 - National Acad Sciences
Adipose tissue is an important metabolic organ, the dysfunction of which is associated with
the development of obesity, diabetes mellitus, and cardiovascular disease. The nuclear …

Macrophage PPARγ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones

AL Hevener, JM Olefsky, D Reichart… - The Journal of …, 2007 - Am Soc Clin Investig
PPARγ is required for fat cell development and is the molecular target of antidiabetic
thiazolidinediones (TZDs), which exert insulin-sensitizing effects in adipose tissue, skeletal …

Novel mechanism of cannabidiol-induced apoptosis in breast cancer cell lines

AS Sultan, MA Marie, SA Sheweita - The Breast, 2018 - Elsevier
Studies have emphasized an antineoplastic effect of the non-psychoactive, phyto-
cannabinoid, Cannabidiol (CBD). However, the molecular mechanism underlying its …

The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR)

MA Peraza, AD Burdick, HE Marin… - Toxicological …, 2006 - academic.oup.com
Peroxisome proliferator-activated receptors (PPARs) are ligand activated transcription
factors that modulate target gene expression in response to endogenous and exogenous …

Peroxisome proliferator-activated receptors (PPARs) and ovarian function–implications for regulating steroidogenesis, differentiation, and tissue remodeling

CM Komar - Reproductive Biology and Endocrinology, 2005 - Springer
The peroxisome proliferator-activated receptors (PPARs) are a family of transcription factors
involved in varied and diverse processes such as steroidogenesis, angiogenesis, tissue …

Peroxisome proliferator activated receptor γ in colonic epithelial cells protects against experimental inflammatory bowel disease

M Adachi, R Kurotani, K Morimura, Y Shah, M Sanford… - Gut, 2006 - gut.bmj.com
Introduction: Peroxisome proliferator activated receptor γ (PPARγ) is expressed in epithelial
cells, macrophage, and T and B lymphocytes. Ligand induced activation of PPARγ was …

Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology

M Schmuth, YJ Jiang, S Dubrac, PM Elias… - Journal of lipid …, 2008 - ASBMB
The epidermis is a very active site of lipid metabolism, and all peroxisome proliferator-
activated receptor (PPAR) and liver X receptor (LXR) isoforms are expressed in the …

[HTML][HTML] Thiazolidinediones as anti-cancer agents

C Blanquicett, J Roman, CM Hart - Cancer therapy, 2008 - ncbi.nlm.nih.gov
The PPAR-gamma (PPAR-γ) activating thiazolidinedione (TZD) medications are a class of
drugs used to improve lipid and glucose metabolism in type-2 diabetes. In addition to their …